Suprima-Plus (Ointment) Instructions for Use
Marketing Authorization Holder
Shreya Life Sciences, Pvt.Ltd. (India)
ATC Code
R05X (Other remedies for the treatment of colds)
Dosage Form
| Suprima-Plus | Ointment: jar 20 g |
Dosage Form, Packaging, and Composition
| Ointment | 100 g |
| Camphor | 7 g |
| Menthol | 6 g |
| Eucalyptus oil | 3 g |
| Thymol | 1.5 g |
| Turpentine oil | 2 g |
Excipients: white beeswax, butylated hydroxyanisole, butylated hydroxytoluene, white petrolatum.
20 g – plastic jars (1) – cardboard packs.
Clinical-Pharmacological Group
A drug with counterirritant action, used for colds, back pain, headache
Pharmacotherapeutic Group
Local irritant
Pharmacological Action
It has a local irritant, local analgesic (counterirritant), and anti-inflammatory effect.
Indications
- Inflammatory diseases of the upper and lower respiratory tract, accompanied by cough, runny nose, feeling of nasal congestion (as part of complex therapy);
- Muscle pain (as a symptomatic remedy).
ICD codes
| ICD-10 code | Indication |
| J00 | Acute nasopharyngitis (common cold) |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04 | Acute laryngitis and tracheitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J20 | Acute bronchitis |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| M79.1 | Myalgia |
| ICD-11 code | Indication |
| CA00 | Acute nasopharyngitis |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| FB56.2 | Myalgia |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For external use only!
To relieve symptoms of inflammatory diseases of the upper and lower respiratory tract, such as cough, runny nose, feeling of nasal congestion – rub into the skin of the chest and back 2-3 times/day.
For muscle pain, apply the ointment to the painful area. To achieve a better result, it is recommended to cover the painful area with a warm bandage.
Do not apply to damaged skin areas.
Adverse Reactions
Possible allergic reactions, skin irritation in the area of application of the drug, bronchospasm.
Contraindications
- Tendency to bronchospasm;
- Damage to the skin in the intended area of application of the drug;
- Hypersensitivity to the components of the drug.
It is not recommended to use for inhalations or apply to the wings of the nose.
Use in Pregnancy and Lactation
Use of the drug in pregnant and breastfeeding mothers is possible only on the recommendation of the attending physician.
Pediatric Use
Not recommended for children under 2 years of age.
Special Precautions
Avoid contact of the drug with eyes and mucous membranes.
Use in pediatrics
Not recommended for children under 2 years of age.
Overdose
No information on cases of overdose is available.
Storage Conditions
Store in a light-protected place, out of reach of children, at a temperature not exceeding 25°C (77°F).
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer